Wijewardana et al., 1990 - Google Patents
Bactericidal activity in the sera of mice vaccinated with Pasteurella multocida type AWijewardana et al., 1990
- Document ID
- 10764680543121941671
- Author
- Wijewardana T
- Sutherland A
- Publication year
- Publication venue
- Veterinary microbiology
External Links
Snippet
The susceptibility of Pasteurella multocida to killing by serum and the ability of protective vaccines to stimulate this mechanism of immunity in mice were investigated. P. multocida type A of bovine origin was used to prepare a vaccine incorporating heat killed organisms …
- 230000000844 anti-bacterial 0 title abstract description 29
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviradae, e.g. avian infectious bronchitis virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lior et al. | Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors | |
SAKAZAKI et al. | O-serogrouping scheme for mesophilic Aeromonas strains | |
Friend et al. | Bovine pneumonic pasteurellosis: experimental induction in vaccinated and nonvaccinated calves. | |
Barnes et al. | Streptococcus iniae: serological differences, presence of capsule and resistance to immune serum killing | |
Stephens | Immune responses of some insects to some bacterial antigens | |
EP0465204B1 (en) | Vaccine against Lyme disease | |
UA121193C2 (en) | Method of making a mycoplasma vaccine | |
Roberts et al. | Serological studies with Mycoplasma synoviae | |
US10758602B2 (en) | Immunogenic composition comprising mycoplasma antigens | |
ES2374278T3 (en) | CANINE VACCINE FOR PROTECTION AGAINST ERLIQUIOSIS. | |
Wijewardana et al. | Bactericidal activity in the sera of mice vaccinated with Pasteurella multocida type A | |
Buchanan et al. | Immunity to gonococcal infection induced by vaccination with isolated outer membranes of Neisseria gonorrhoeae in guinea pigs | |
Hodgins et al. | Serologic responses of young colostrum fed dairy calves to antigens of Pasteurella haemolytica A1 | |
Heesemann et al. | Analysis of the class-specific immune response to Yersinia enterocolitica virulence-associated antigens in oro-gastrically infected rabbits | |
Baldwin et al. | Immune response of cattle to Brucella abortus outer membrane proteins measured by lymphocyte blastogenesis | |
Fedorka-Cray et al. | The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison | |
Maheswaran et al. | Studies on Pasteurella multocida. III. In vitro assay for cell-mediated immunity | |
De Cueninck et al. | Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide | |
RU2472525C2 (en) | Universal vaccine for treating and preventing lyme disease applicable in human and veterinary science, and method for preparing it | |
Frasch et al. | Protection against group B meningococcal disease. II. Infection and resulting immunity in a guinea pig model. | |
Linggood et al. | An examination of the O and K specificity involved in the antibody-induced loss of the K88 plasmid from porcine enteropathogenic strains of Escherichia coli. | |
HIGUCHI et al. | Isolation of virulent Rhodococcus equi from transtracheal aspirates of foals serodiagnosed by enzyme-linked immunosorbent assay | |
Ortiz et al. | Suppression of the humoral immune response to inactivated Newcastle disease virus by Mycoplasma meleagridis in the Turkey | |
Herzog et al. | The efficacy of a temperature-sensitive mutant vaccine against Northwest Arkansas isolates of Alcaligenes faecalis | |
Keisler et al. | A serologic survey in ewes treated with one of two Chlamydia/Campylobacter vaccines |